Article
PSA doubling of <3 months points to eventual death
Chicago-A post-treatment PSA doubling time less than 3 months followingeither surgery or radiation for localized or locally advanced prostate cancercan be a surrogate marker for eventual-perhaps inevitable-death from thedisease, according to data from a multicenter study of nearly 9,000 cancerpatients.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Related Content
![Continuing an ARPI with [177Lu]Lu-PSMA-617 may not provide additional benefit in mCRPC](https://cdn.sanity.io/images/0vv8moc6/urologytimes/3f3104f5151a9c5bd47e129a09e8443bd772afdc-1200x905.jpg?fit=crop&auto=format)
